애프터마켓
로그인 회원가입
BAX
BAX
Baxter International Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$23.34
+0.94 ▲ +4.20%
🌙 7월 27일 4:34 PM ET (한국 7/28 05:34)
$23.30
-0.04 ▼ -0.17%

벡스터 인터내셔널(BAX) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$12.1B
미드캡
P/E
-
배당수익률
0.47%
52주 위치
56%
저점 +48% · 고점 -20%
애널리스트
보유
D
Fundamental health
vs. Medical Instruments & Supplies
수익성
Top 61%
성장
Top 83%
밸류에이션
Top 79%
재무 안정
Top 30%
💰 Is this stock pricier than usual right now?
Compared to this company's own recent 2년 (not other companies).
Very cheap
Cheap
Typical
Pricey
🔥 Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 135원. Over the past 2년, it usually traded around 31원. One of the priciest stretches of the past 2년.
Pricy doesn't mean bad — it means expectations are already baked in.· based on 2.4 profitable years
Index S&P 500P/E -EPS (ttm) -1.95Insider Own 0.95%Shs Outstand 516.5MPerf Week 5.75%
Market Cap 12.05BForward P/E 11.8EPS next Y 2.9%Insider Trans -Shs Float 511.5MPerf Month 8.31%
Enterprise Value 19.70BPEG -EPS next Q 0.37Inst Own 104%Short Float 7.2%Perf Quarter 28.52%
Income -1.00BP/S 1.06EPS this Y -13.04%Inst Trans -3.79%Short Ratio 5.26Perf Half Y 17.64%
Sales 11.32BP/B 1.99EPS next 5Y -1.04%ROA -4.77%Short Interest 36.84MPerf YTD 22.14%
Book/sh 11.7P/C 5.98EPS past 3/5Y 24.78% -ROE -14.95%52W High -20.48% ($29.35)Perf Year -20.12%
Cash/sh 3.91P/FCF 16.67Sales past 3/5Y -8.14% -0.75%ROIC -6.74%52W Low 48.38% ($15.73)Perf 3Y -48.68%
Dividend Est. $0.11 (0.47%)EV/EBITDA 12.38EPS Y/Y TTM -78.01%Gross Margin 32.05%Volatility(W/M) 2.73% 3.13%Perf 5Y -71.57%
Dividend TTM 0.2EV/Sales 1.74Sales Y/Y TTM -4.79%Oper. Margin 5.48%ATR (14) 0.79Perf 10Y -51.7%
Dividend Ex-Date 2026/5/29Quick Ratio 1.23EPS Q/Q -111.87%Profit Margin -8.87%RSI (14) 62.04Recom 2.8
Dividend Gr. 3/5Y -23.25% -11.35%Current Ratio 1.85Sales Q/Q 2.9%SMA20 4.64% ($22.31)Beta 0.6Target Price $20.44
Payout -Debt/Eq 1.6Earnings 2026/7/30SMA50 13.17% ($20.62)Rel Volume 0.78Prev Close $22.4
Employees 37500LT Debt/Eq 1.46EPS/Sales Surpr. 18.97% 3.27%SMA200 19.6% ($19.52)Avg Volume(3M) 7.01MPrice $23.34
IPO 1961/5/16Option/Short Yes/YesTrades 25991Volume 5,444,809Change 4.2%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12
25.3
25.6
25.9
25.12*
26.3
Revenue Net income 최근 분기: 매출 $2.7B (YoY +3%) · 순이익 $-15M (YoY -112%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Baxter International Inc (BAX) Investment Analysis

What kind of company is Baxter International Inc?

벡스터 인터내셔널(BAX) 방어주
Healthcare · Medical Instruments & Supplies
#854 by Market Cap — Mid-Cap

A U.S. medical device and pharmaceutical company, this global medical products firm manufactures IV (intravenous) solutions, infusion pumps, and hospital-grade medical products, supplying them to hospitals and healthcare facilities. Demand for essential hospital products provides a stable foundation for the business.

Learn more about Baxter International Inc →
Market Cap
$12.1B
Approx. KRW 16.5 trillion
⚖️ 4% of Samsung Electronics
Market Cap Rank854
Employees37,500people
IPO1961/05/16
Current Price$23.34 ≈ 31,976원
📌 S&P 500 · NYSE · USA

Key Events

⏰ Upcoming events
🔔 Earnings release D-3
예상 EPS $0.37
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🎯 Ex-div 2026년 5월 29일 (금) 주당 $0.01
🔔 Earnings release 2026년 4월 30일 (목) · 장 시작 전 EPS +19.0% 매출 +3.3%
🎯 Ex-div 2026년 2월 27일 (금) 주당 $0.01
🔔 Earnings release 2026년 2월 12일 (목) · 장 시작 전

Is it profitable?

Financially sound but profitability is low
Losses or thin margins — early-stage growth or weakening competitiveness
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
5.5%
✓ 양호
My positionMid-range
Low range Average High range
Medical Instruments & Supplies Median 5.5% · Around average
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
-8.9%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
32.0%
✓ 평균
My positionMid-range
Low range Average High range
Medical Instruments & Supplies Median 48.6% · Bottom 29%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
-14.9%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
ROA
Annual earnings relative to total company assets
-4.8%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
ROIC
Return generated per dollar invested in the business
-6.7%
✓ 적자
💡 적자 상태 — 수익을 내지 못하고 있습니다
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
1.60
✓ Very high debt
My positionBottom 5%
Low range Average High range
Medical Instruments & Supplies Median 0.26
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
1.85
✓ 양호
My positionMid-range
Low range Average High range
Medical Instruments & Supplies Median 2.34
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.23
✓ 양호
My positionMid-range
Low range Average High range
Medical Instruments & Supplies Median 1.97
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$20.44
현재가 대비 -12.4%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
11.80배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
내년 EPS 예상 성장률
+2.9%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
-1.0%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Average Earnings Performance
Mixed beats and misses
1
예상 상회
0
예상 부합
1
예상 하회
50%
상회 비율
-0.9%
평균 서프라이즈
2026.04.30
상회
실적 $0.36 · 예상 $0.31 +15.9%
2026.02.12
하회
실적 $0.44 · 예상 $0.54 -17.8%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Growth Concerns
Growth is lagging the industry average
Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
-13.0%
매우 부진
My positionBottom 5%
Low range Average High range
방어주 대형주 Median 9.6% · Bottom tier
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+2.9%
매우 부진
My positionBottom 5%
Low range Average High range
방어주 대형주 Median 10.8% · Bottom tier
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
-1.0%
매우 부진
My positionBottom 5%
Low range Average High range
방어주 대형주 Median 9.8% · Bottom tier
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+24.8%
우수
My positionTop 25%
Low range Average High range
방어주 대형주 Median 4.7% · Top 21%
Past 5-Year Revenue
How much revenue grew over the past 5 years
-0.8%
매우 부진
My positionBottom 5%
Low range Average High range
방어주 대형주 Median 6.7% · Bottom tier
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+2.9%
평균
My positionMid-range
Low range Average High range
방어주 대형주 Median 8.4% · Bottom 25%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Long-term weakness — -140%p below the market
BAX -71.6% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-139.9%p
Significantly behind the market
vs Health Care (XLV)
-96.1%p
Significantly behind the sector average
1-year basis
vs S&P 500
-36.1%p
Significantly behind the market
vs Health Care (XLV)
-39.8%p
Significantly behind the sector average
Current position within 52-week range
Low (-48.4%p) High (-20.5%p)
Current price is 48.4% above the 52-week low and 20.5% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-29.0%
Annualized volatility
48.7%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 137-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢
Current diagnosis · 2026-07-27
Uptrend zone

Current price $23.34 above the midline ($22.30). Normal upward flow. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡
Current diagnosis · 2026-07-27
Neutral zone — weak trend

MACD 0.514 · Signal 0.594 · Hist -0.080. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢
Current diagnosis · 2026-07-27
Bullish zone

RSI 62.0 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 85.5.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Earnings·Vs. Assets·Vs. Sales·Vs. Cash Flow
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Cheap
🏢 Vs. Assets Cheap
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Cheap
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
11.80x
✓ Very cheap
My positionTop 25%
Low range Average High range
Medical Instruments & Supplies median 18.44x · Top 14% — relatively cheap within the industry
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
1.99x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Instruments & Supplies median 2.71x · Around the industry average
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
1.06x
✓ Very cheap
My positionTop 25%
Low range Average High range
Medical Instruments & Supplies median 2.92x · Top 15% — relatively cheap within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
12.38x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Instruments & Supplies median 14.76x · Around the industry average
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
16.67x
✓ Very cheap
My positionTop 25%
Low range Average High range
Medical Instruments & Supplies median 25.16x · Top 13% — relatively cheap within the industry
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$20.44 vs. current price -12.4%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Medical Instruments & Supplies

Who owns it?

Ownership flow shows some pressure
Institutional net selling -3.8% · Short interest moderate 7.2%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
-3.8%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 104.0%
Institution-led, stable structure
Healthcare 대형주 Median 91.9%
🧑‍💼 Insiders 0.9%
Low, common among large-caps
Healthcare 대형주 Median 0.8%
👤 Retail investors (estimated) 0.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
7.2%
Moderate
Healthcare 대형주 Median 3.6%
Past 90 days Little change
Short interest days to cover
5.3 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 516.5M주
Float (tradable shares) 511.5M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding BAX

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당 지급 — 연 0.47%
배당보다 주가 성장에 가까운 비중
Dividend Yield
0.47%
Industry average 1.23%
Dividend Per Share
$0.11
Annualized
Payout Ratio
-
Share of net income paid as dividends
5-Year Growth
-11.3%
Annualized dividend growth
📅 지급월 2월 · 8월 · 11월
📊 총 이력 1982~2026 (158건)
연도별 배당 총액 추이
주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.
$0.51 -36.5%
2016
$0.61 +20.8%
2017
$0.73 +19.7%
2018
$0.85 +16.4%
2019
$0.95 +12.4%
2020
$1.08 +13.6%
2021
$1.15 +6.0%
2022
$1.16 +0.9%
2023
$1.04 -10.3%
2024
$0.52 -50.0%
2025
$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소
최근 배당 이력 총 158건
아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.
배당락일
주당 금액
지급일
당시 수익률
2026-02-27
$0.010
2.60%
2025-11-28
$0.010
3.68%
2025-08-29
$0.170
3.93%
2025-05-30
$0.170
3.57%
2025-02-28
$0.170
3.51%
2024-11-29
$0.170
3.95%
2024-08-30
$0.290
3.82%
2024-05-31
$0.290
4.25%
2024-02-29
$0.290
2.83%
2023-11-30
$0.290
4.02%
2023-08-31
$0.290
3.57%
2023-06-01
$0.290
3.52%
2023-02-23
$0.290
3.55%
2022-12-01
$0.290
2.73%
2022-09-01
$0.290
2.50%
2022-06-02
$0.290
1.90%
2022-02-24
$0.280
1.61%
2021-12-02
$0.280
1.74%
2021-09-02
$0.280
1.30%
2021-06-03
$0.280
1.54%
2021-02-25
$0.245
1.53%
2020-12-03
$0.245
1.54%
2020-08-28
$0.245
1.34%
2020-06-04
$0.245
1.27%
2020-02-27
$0.220
1.27%
2019-12-05
$0.220
1.03%
2019-08-29
$0.220
1.15%
2019-06-06
$0.220
1.03%
2019-02-28
$0.190
1.23%
2018-11-30
$0.190
1.30%
2018-08-30
$0.190
1.16%
2018-05-31
$0.190
1.17%
2018-03-01
$0.160
1.16%
2017-11-30
$0.160
1.13%
2017-08-30
$0.160
1.15%
2017-05-31
$0.160
1.15%
2017-03-01
$0.130
1.24%
2016-11-30
$0.130
1.40%
2016-08-31
$0.130
1.29%
2016-06-01
$0.130
1.10%
2016-03-02
$0.115
2.29%
2015-12-02
$0.115
2.88%
2015-09-02
$0.115
3.33%
2015-05-28
$0.282
3.87%
2015-03-09
$0.282
3.07%
2014-12-03
$0.282
3.45%
2014-09-03
$0.282
3.39%
2014-06-04
$0.282
3.40%
2014-03-05
$0.266
3.55%
2013-12-04
$0.266
3.55%
2013-09-04
$0.266
3.34%
2013-06-05
$0.266
3.16%
2013-03-06
$0.244
2.89%
2012-12-05
$0.244
2.95%
2012-09-05
$0.244
3.04%
2012-06-06
$0.182
3.23%
2012-03-07
$0.182
2.78%
2011-12-07
$0.182
3.10%
2011-09-07
$0.168
2.75%
2011-06-08
$0.168
2.61%
2011-03-08
$0.168
2.81%
2010-12-08
$0.168
2.97%
2010-09-08
$0.158
3.30%
2010-06-08
$0.158
3.39%
2010-03-08
$0.158
1.86%
2009-12-08
$0.158
2.41%
2009-09-08
$0.141
2.26%
2009-06-08
$0.141
2.15%
2009-03-06
$0.141
2.26%
2008-12-08
$0.141
1.75%
2008-09-08
$0.118
1.28%
2008-06-06
$0.118
1.35%
2008-03-06
$0.118
1.64%
2007-12-06
$0.118
2.19%
2007-09-06
$0.091
2.02%
2007-06-06
$0.091
1.61%
2007-03-07
$0.091
1.54%
2006-12-06
$0.316
2.59%
2005-12-07
$0.316
2.99%
2004-12-08
$0.316
3.62%
2003-12-10
$0.316
3.93%
2002-12-11
$0.316
4.04%
2001-12-12
$0.316
2.29%
2000-12-13
$0.316
4.56%
2000-04-03
$0.737
5.76%
1999-12-08
$0.079
2.32%
1999-09-22
$0.079
1.89%
1999-06-09
$0.079
2.17%
1999-03-10
$0.079
1.99%
1998-12-09
$0.079
1.84%
1998-09-08
$0.079
2.44%
1998-06-09
$0.079
2.62%
1998-03-10
$0.079
2.02%
1997-12-08
$0.079
2.80%
1997-09-08
$0.077
9.28%
1997-06-09
$0.077
9.41%
1997-03-06
$0.082
10.82%
1996-12-09
$0.077
12.10%
1996-10-01
$0.978
10.71%
1996-09-09
$0.082
3.22%
1996-06-10
$0.082
3.14%
1996-03-11
$0.077
2.47%
1995-12-11
$0.077
2.70%
1995-09-11
$0.077
2.85%
1995-06-12
$0.077
3.12%
1995-03-09
$0.071
3.34%
1994-12-01
$0.071
4.97%
1994-08-31
$0.071
4.45%
1994-06-02
$0.068
4.81%
1994-03-03
$0.068
5.56%
1993-12-02
$0.068
5.20%
1993-09-01
$0.068
4.30%
1993-06-03
$0.068
3.72%
1993-03-04
$0.068
3.61%
1992-12-03
$0.058
2.88%
1992-09-02
$0.053
2.80%
1992-06-04
$0.053
2.66%
1992-03-05
$0.053
2.71%
1991-12-05
$0.046
2.44%
1991-09-05
$0.046
2.48%
1991-06-06
$0.046
2.57%
1991-03-07
$0.046
2.56%
1990-12-06
$0.039
2.74%
1990-09-06
$0.039
3.23%
1990-06-07
$0.039
3.15%
1990-03-08
$0.039
2.89%
1989-12-07
$0.035
2.24%
1989-09-07
$0.035
2.38%
1989-06-08
$0.035
2.54%
1989-03-09
$0.035
2.68%
1988-12-06
$0.031
3.41%
1988-09-06
$0.031
2.87%
1988-06-07
$0.031
2.65%
1988-03-08
$0.031
2.22%
1987-12-08
$0.027
2.36%
1987-09-08
$0.027
2.02%
1987-06-09
$0.027
2.24%
1987-03-10
$0.027
2.06%
1986-12-09
$0.025
2.43%
1986-09-09
$0.025
2.81%
1986-06-10
$0.025
1.97%
1986-03-11
$0.025
2.62%
1985-12-09
$0.023
2.37%
1985-09-09
$0.023
2.47%
1985-06-04
$0.023
2.84%
1985-03-13
$0.023
2.82%
1984-12-03
$0.020
3.28%
1984-08-31
$0.020
2.30%
1984-06-05
$0.020
2.39%
1984-03-14
$0.020
2.10%
1983-12-05
$0.017
1.51%
1983-09-02
$0.017
1.09%
1983-06-07
$0.017
1.18%
1983-03-16
$0.017
0.94%
1982-12-06
$0.014
0.95%
1982-09-03
$0.014
0.80%
1982-06-07
$0.014
0.68%
1982-03-10
$0.014
0.35%
* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.
💰 내가 100만원 투자한다면
연간 배당금 (세후) 4,006원
5년 누적 (세후) 1.6만원
* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 -11.35% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
BAX BAX This Stock
$12.1B- 2.0 -14.95% 0.47% +4.2%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 벡스터 인터내셔널(BAX)?

벡스터 인터내셔널(BAX) belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is the market cap of BAX?

The market cap of BAX is approximately $12.1B, ranking 854 within its sector.

Does BAX pay dividends?

BAX has a dividend yield of approximately 0.47%, with an annual dividend of $0.11.

What is the 52-week high and low for BAX?

BAX has recorded a 52-week high of $29.35 and a low of $15.73.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.